StonvexLoading…
StonvexStonvexStonvexCore line items from DJT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $871.20K | $3.68M | $2.68M | $1.70M |
Operating Income | $-293.49M | $-573.04M | $-140.70M | $-83.04M |
Net Income | $-405.88M | $-712.34M | $-106.58M | $-20.00M |
EPS (Diluted) | $-1.47 | $-2.80 | $-0.43 | $-0.22 |
Total Assets | $2.24B | $2.63B | $3.27B | $3.25B |
Total Liabilities | $983.45M | $982.82M | $986.98M | $965.13M |
Cash & Equivalents | $249.07M | $134.56M | $166.07M | $1.34B |
Free Cash Flow OCF − CapEx | $17.88M | $14.18M | $2.07M | $-7.99M |
Shares Outstanding | 276.74M | 276.72M | 246.53M | 230.60M |